Skip to main content

Tempest Therapeutics, Inc 8-K, filed Nov 16, 2026

Tempest Therapeutics, Inc. (TPST)

8-K 2026-11-16 For: 2026-11-12
View Original
Added on November 17, 2026

About this 8-K

Tempest Therapeutics, Inc filed this 8-K on November 16, 2026, reporting on events of November 12, 2026.

Tempest Therapeutics adjourned its reconvened special meeting to December 11, 2026, after not having enough votes to approve a charter amendment replacing supermajority voting and allowing stockholder written consent. A quorum of 74.64% of shares was present. AI summary

Items reported

  • Item 5.07: Shareholder vote results
  • Item 8.01: Other events